Review




Structured Review

Dexcom Inc standalone cgm dexcom g5 mobile
Disease Interventions and Comparators Evaluated in the Primary Economic Model
Standalone Cgm Dexcom G5 Mobile, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standalone+cgm+dexcom+g5+mobile/standalone+cgm+dexcom+g5+mobile/pmc05836597-214-0-6
Average 90 stars, based on 1 article reviews
standalone cgm dexcom g5 mobile - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment"

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

Journal: Ontario Health Technology Assessment Series

doi:

Disease Interventions and Comparators Evaluated in the Primary Economic Model
Figure Legend Snippet: Disease Interventions and Comparators Evaluated in the Primary Economic Model

Techniques Used:

Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a
Figure Legend Snippet: Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a

Techniques Used:

Change in A1C From Baseline and Risk Reduction for Diabetes Complications
Figure Legend Snippet: Change in A1C From Baseline and Risk Reduction for Diabetes Complications

Techniques Used:

Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario
Figure Legend Snippet: Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Techniques Used:

Daily and Annual Costs of Diabetes Treatment Supplies a
Figure Legend Snippet: Daily and Annual Costs of Diabetes Treatment Supplies a

Techniques Used:

Annual Costs of Continuous Glucose Monitoring and Insulin Pump a
Figure Legend Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Techniques Used: Battery

Cost to Patient of Technologies With Various Levels of Government Funding
Figure Legend Snippet: Cost to Patient of Technologies With Various Levels of Government Funding

Techniques Used:

Base Case Analysis
Figure Legend Snippet: Base Case Analysis

Techniques Used:

Scenario 1 Results a
Figure Legend Snippet: Scenario 1 Results a

Techniques Used:

Scenario 2 Results
Figure Legend Snippet: Scenario 2 Results

Techniques Used:

Scenario 3 Results
Figure Legend Snippet: Scenario 3 Results

Techniques Used:

Scenario 4 Results
Figure Legend Snippet: Scenario 4 Results

Techniques Used:

Scenario 5 Results
Figure Legend Snippet: Scenario 5 Results

Techniques Used:

Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group
Figure Legend Snippet: Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group

Techniques Used:

Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections
Figure Legend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections

Techniques Used:

Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections
Figure Legend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections

Techniques Used:

Reasons for Including Four Interventions in the Primary Economic Analysis
Figure Legend Snippet: Reasons for Including Four Interventions in the Primary Economic Analysis

Techniques Used:

Related Articles

Battery:

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , Dexcom b.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Biomarker Discovery:

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , Dexcom b.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Control:

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , Dexcom b.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Injection:

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , Dexcom b.

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment
Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.



Similar Products

90
Dexcom Inc standalone cgm dexcom g5 mobile
Disease Interventions and Comparators Evaluated in the Primary Economic Model
Standalone Cgm Dexcom G5 Mobile, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standalone+cgm+dexcom+g5+mobile/standalone+cgm+dexcom+g5+mobile/pmc05836597-214-0-6
Average 90 stars, based on 1 article reviews
standalone cgm dexcom g5 mobile - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Disease Interventions and Comparators Evaluated in the Primary Economic Model

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Disease Interventions and Comparators Evaluated in the Primary Economic Model

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Change in A1C From Baseline and Risk Reduction for Diabetes Complications

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Change in A1C From Baseline and Risk Reduction for Diabetes Complications

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Daily and Annual Costs of Diabetes Treatment Supplies a

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Daily and Annual Costs of Diabetes Treatment Supplies a

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques: Battery

Cost to Patient of Technologies With Various Levels of Government Funding

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Cost to Patient of Technologies With Various Levels of Government Funding

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Base Case Analysis

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Base Case Analysis

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Scenario 1 Results a

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 1 Results a

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Scenario 2 Results

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 2 Results

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Scenario 3 Results

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 3 Results

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Scenario 4 Results

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 4 Results

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Scenario 5 Results

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 5 Results

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques:

Reasons for Including Four Interventions in the Primary Economic Analysis

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Reasons for Including Four Interventions in the Primary Economic Analysis

Article Snippet: Standalone CGM plus multiple daily injections (Dexcom G5 Mobile) , 8,587 , 8,587 , 7,239 , 6,134 , 7,482.

Techniques: